Clinical predictors of response in metastatic germ cell tumors

Grant Taylor, David J. Perry, Robert D. Knight, Nancy A. Dawson, Steven J. Skoog, David G. McLeod

Research output: Contribution to journalArticle

Abstract

Twenty‐two patients with bulky, metastatic germ cell tumors were treated with cyclophosphamide, vinblastine, dactinomycin, bleomycin, and cisplatin (VAB) alternating with VP‐16 and vincristine (VV). The overall complete response rate after chemotherapy with or without surgical excision of residual tissue was 63% (14 of 22 patients) with a median survival of 46 months. Five patients are dead of disease progression and three are alive beyond 3 years with only residual radiographic abnormalities. A retrospective analysis of prognostic variables (numbers of sites of disease, tumor marker levels) using two previously published prognosis formulas demonstrated a good correlation between prognostic variables (numbers of sites of disease, tumor marker levels) and the clinical assessment of prognosis based on tumor bulk and tumor marker level. Nevertheless, individual patients with other, unknown prognostic features may be incorrectly evaluated using either established formulas or clinical assessment of tumor bulk.

Original languageEnglish (US)
Pages (from-to)217-221
Number of pages5
JournalCancer
Volume62
Issue number1
DOIs
StatePublished - Jul 1 1988

    Fingerprint

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this